Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Huber

Showing results (321-330 of 752) with videos related to

Pageof 76
Sort By:
Bone|November 17, 2010
Markers of bone metabolism in premature myocardial infarction (≤ 40 years of age)Georg Goliasch, Hermann Blessberger, Danyel Azar, et al.
Stroke|September 22, 2007
Progression of carotid stenosis detected by duplex ultrasonography predicts adverse outcomes in cardiovascular high-risk patientsSchila Sabeti, Oliver Schlager, Markus Exner, et al.
European Heart Journal|March 12, 2009
Familial-combined hyperlipidaemia in very young myocardial infarction survivors (< or =40 years of age)Franz Wiesbauer, Hermann Blessberger, Danyel Azar, et al.
Wiener Klinische Wochenschrift|June 26, 2013
[Periprocedual management of vitamin K antagonist's with low molecular weight heparins during invasive procedures--Consensus of experts]Herbert Watzke, Helfried Metzler, Ansgar Weltermann, et al.
Thrombosis Research|August 24, 2020
Von Willebrand Factor and ADAMTS13 and long-term outcomes in patients undergoing percutaneous coronary interventionMaximilian Tscharre, Ioannis Tentzeris, Birgit Vogel, et al.
Critical Care Medicine|June 22, 2010
Prediction of cardiogenic shock using plasma B-type natriuretic peptide and the N-terminal fragment of its pro-hormone [corrected] concentrations in ST elevation myocardial infarction: an analysis from the ASSENT-4 Percutaneous Coronary Intervention TrialRudolf Jarai, Kurt Huber, Kris Bogaerts, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 4, 2010
The complement component C5a is present in human coronary lesions in vivo and induces the expression of MMP-1 and MMP-9 in human macrophages in vitroWalter S Speidl, Stefan P Kastl, Randolph Hutter, et al.
European Heart Journal|May 27, 2005
Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosisWalter S Speidl, Markus Exner, Jasmin Amighi, et al.
Thrombosis and Haemostasis|April 9, 2008
Time course of prothrombotic and proinflammatory substance release after intracoronary stent implantationPaul Wexberg, Nelli Jordanova, Christoph Strehblow, et al.
British Journal of Haematology|April 26, 2002
Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery diseaseGeorg Endler, Alexandra Klimesch, Heike Sunder-Plassmann, et al.
Pageof 76

Showing results (321-330 of 752) with videos related to

Sort By:
Pageof 76
Bone|November 17, 2010
Markers of bone metabolism in premature myocardial infarction (≤ 40 years of age)Georg Goliasch, Hermann Blessberger, Danyel Azar, et al.
Stroke|September 22, 2007
Progression of carotid stenosis detected by duplex ultrasonography predicts adverse outcomes in cardiovascular high-risk patientsSchila Sabeti, Oliver Schlager, Markus Exner, et al.
European Heart Journal|March 12, 2009
Familial-combined hyperlipidaemia in very young myocardial infarction survivors (< or =40 years of age)Franz Wiesbauer, Hermann Blessberger, Danyel Azar, et al.
Wiener Klinische Wochenschrift|June 26, 2013
[Periprocedual management of vitamin K antagonist's with low molecular weight heparins during invasive procedures--Consensus of experts]Herbert Watzke, Helfried Metzler, Ansgar Weltermann, et al.
Thrombosis Research|August 24, 2020
Von Willebrand Factor and ADAMTS13 and long-term outcomes in patients undergoing percutaneous coronary interventionMaximilian Tscharre, Ioannis Tentzeris, Birgit Vogel, et al.
Critical Care Medicine|June 22, 2010
Prediction of cardiogenic shock using plasma B-type natriuretic peptide and the N-terminal fragment of its pro-hormone [corrected] concentrations in ST elevation myocardial infarction: an analysis from the ASSENT-4 Percutaneous Coronary Intervention TrialRudolf Jarai, Kurt Huber, Kris Bogaerts, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 4, 2010
The complement component C5a is present in human coronary lesions in vivo and induces the expression of MMP-1 and MMP-9 in human macrophages in vitroWalter S Speidl, Stefan P Kastl, Randolph Hutter, et al.
European Heart Journal|May 27, 2005
Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosisWalter S Speidl, Markus Exner, Jasmin Amighi, et al.
Thrombosis and Haemostasis|April 9, 2008
Time course of prothrombotic and proinflammatory substance release after intracoronary stent implantationPaul Wexberg, Nelli Jordanova, Christoph Strehblow, et al.
British Journal of Haematology|April 26, 2002
Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery diseaseGeorg Endler, Alexandra Klimesch, Heike Sunder-Plassmann, et al.
Pageof 76